Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients

Journal of Immunology

Volumn 160, Issue 12, 1998, Pages 6204-6209

  Haque, Tanzina ^a,b   Amlot, Peter L ^c   Helling, Nabeela ^b   Thomas, J Alero ^b   Sweny, Paul ^c   Rolles, Keith ^c   Burroughs, Andrew K ^c   Prentice, H Grant ^c   Crawford, Dorothy H ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CASE REPORT; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS RESISTANCE;

EID: 0032526334     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pope, J. H., M. K. Home, and W. Scott. 1968. Transformation of human fetal leucocytes in vitro by infiltrates of a human leukemia cell line containing herpes-like virus. Int. J. Cancer 3:857.
2. Miyashita, E. M., B. Yang, K. M. C. Lam, D. H. Crawford, and D. A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells. Cell 80:593.
3. Sixbey, J. W., J. G. Nedrud, N. Raab-traub, R. A. Hanes, and J. S. Pagano. 1984. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1225.
4. Moss, D. J., L. E. Wallace, A. B. Rickinson, and M. A. Epstein. 1978. Cytotoxic T-cell recognition of Epstein-Barr virus infected B-cells. I. Specificity and HLA-restriction of effector cells reactivated in vitro. Eur. J. Immunol. 11:686.
5. Wallace, C. E., A. B. Rickinson, M. Rowe, and M. A. Epstein. 1982. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature 297:413.
6. Savoie, A., C. Perpete, L. Carpentier, J. Joncas, and C. Alfieri. 1994. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 9:2715.
7. Thomas, J. A., D. H. Crawford, and M. Burke. 1995. Clinicopathological implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients, J. Clin. Pathol. 48:287.
8. Starzl, T. E., K. A. Porter, S. Iwatsuki, J. T. Rosenthal, B. W. Shaw, Jr., R. W. Atchison, M. A. Nalesnik, M. Ho, B. P. Griffith, T. R. Hakala, R. L. Hardesly, and R. Jaffe. 1984. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583.
9. Hunt, B. J., J. A. Thomas, M. Burke, H. Walker, M. Yacoub, and D. H. Crawford. 1996. Epstein-Barr virus associated Burkitt's lymphoma in a heart transplant recipient. Transplantation 62:869.
10. Papadopoulos, E. B., M. Ladanyi, D. Emanuel, S. Mackinnon, F. Boulad, M. H. Carabasi, H. Castro-Malaspina, B. H. Childs, A. P. Gillio, T. Small, J. W. Young, N. A. Keman, and R. J. O'Reilly. 1994. Infusions of donor leukocytes to treat Epstein-barr virus-associated lymphoproliferalive disorders after allogenic bone marrow transplantation. N. Engl. J. Med. 330:1185.
11. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science 257:238.
12. Rooney, C. M., C. A. Smith, C. Y. C. Ng. S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9.
13. Hesiop, H. E., C. Y. C. Ng, C. Li, C. A. Smith, S. K. Loftin, R. A. Krance, M. K. Brenner, and C. M. Rooney. 1996. Nat. Med. 2:551.
14. Boyum, A. 1968. Separation of leucocytes from blood and bone marrow. Scan. J. Clin. Lab. Invest. 21(Suppl. 97):31.
15. Miller, G., T. Shope, H. Lisco, D. Stitt, and A. Lipman. 1972. Epstein-Barr virus: transformation cytopathic changes and viral antigens in squirrel monkey and marmoset leukocytes. Proc. Natl. Acad. Sci. USA 69:383.
16. Henle, G., and W. Henle. 1966. Immunofluorescence in cells derived from Burkitt's lymphoma. J. Bacteriol. 91:1248.
17. Smith, C. A., C. Y. C. Ng, H. E. Heslop, M. S. Holladay, S. Richardson, E. V. Turner, S. K. Loftin, C. Li, M. K. Brenner, and C. M. Rooney. 1995. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J. Hematother. 4:73.
18. Lozzio, C. B., and B. B. Lozzio. 1975. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321.
19. Amlot, P. L., F. Tahami, D. Chinn, and E. Rawlings. 1996. Activation antigen expression on human T cells. I. Analysis by two-color flow cytometry of umbilical cord blood, adult blood and lymphoid tissue. Clin. Exp. Immunol. 105:176.
20. Middleton, P. G., S. Miller, J. A. Ross, C. M. Steel, and K. Guy. 1992. Insertion of SMRV-H viral DNA at the c-myc gene locus of a BL cell line and presence in established cell lines. Int. J. Cancer 52:451.
21. Colby, B., J. Shaw, G. Elion, and J. Pagano. 1980. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J. Virol. 34:560.
22. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HlV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249.
23. Strijbosch, L. W. G., W. A. Buurman, R. J. M. M. Does, P. H. Zinken, and G. Groenegen. 1987. Limiting dilution assays: experimental design and statistical analysis. J. Immunol. Methods 97:133.
24. Klein, G., B. C. Giovanella, A. Westman, J. S. Stehlin, and D. Mumford. 1975. An EBV-genome negative cell line established from an American Burkitt lymphoma: receptor characteristics, EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5:319.
25. Saiki, R. K., S. Scharf, F. Faloona, K. B. Mullis, G. T. Horn, H. A. Erlich, and N. Arnheim. 1985. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350.
26. Boyle, M. J., W. A. Sewell, T. B. Sculley, A. Apolloni, J. J. Turner, C. E. Swanson, R. Penny, and D. A. Cooper. 1991. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 78:3004.
27. Adldinger, H. K., H. Delius, U. K. Freese, J. Clarke, and G. W. Bornkamm. 1985. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:221.
28. Henderson, A., S. Ripley, M. Heller, and E. Kieff. 1983. Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc. Natl. Acad. Sci. USA 80:1987.
29. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocyles, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14:9.